Satter Investment Management logo

Satter Investment Management

North America, Illinois, United States, Chicago

Description

Satter Investment Management is a principal investment firm specializing in investments in life sciences and medical technology companies.

Investor Profile

Satter Investment Management has backed more than 10 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 20% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Therapeutics, Health Care.

Stage Focus

  • Series C (40%)
  • Series A (20%)
  • Series Unknown (10%)
  • Post Ipo Equity (10%)
  • Post Ipo Secondary (10%)
  • Series B (10%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Health Diagnostics
  • Life Science
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Satter Investment Management frequently co-invest with?

Athenian Venture Partners
North America, Florida, United States, Fort Lauderdale
Co-Investments: 3
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 2
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 7
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 3
Kearny Venture Partners
North America, California, United States, San Francisco
Co-Investments: 4
Triathlon Medical Venture Partners
North America, Ohio, United States, Cincinnati
Co-Investments: 4
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 3
Venture Investors
North America, Wisconsin, United States, Madison
Co-Investments: 4
AgeChem Venture Fund
North America, Quebec, Canada, Montréal
Co-Investments: 2

What are some of recent deals done by Satter Investment Management?

Annexon Biosciences

South San Francisco, California, United States

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceTherapeutics
Post Ipo EquityJul 8, 2022
Amount Raised: $130,000,000
Aileron Therapeutics

Cambridge, Massachusetts, United States

Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.

BiopharmaBiotechnologyTherapeutics
Post Ipo SecondaryJan 6, 2021
Amount Raised: $35,900,000
Annexon Biosciences

South San Francisco, California, United States

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceTherapeutics
Series CJul 1, 2020
Amount Raised: $100,000,000
Annexon Biosciences

South San Francisco, California, United States

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceTherapeutics
Series CDec 19, 2018
Amount Raised: $75,000,000
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series UnknownMar 16, 2017
Amount Raised: $40,000,000
Annexon Biosciences

South San Francisco, California, United States

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceTherapeutics
Series BJun 23, 2016
Amount Raised: $44,000,000
Annexon Biosciences

South San Francisco, California, United States

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceTherapeutics
Series ADec 15, 2014
Amount Raised: $34,000,000
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series CApr 23, 2014
Amount Raised: $22,000,000
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series ANov 6, 2013
Amount Raised: $36,000,000
Akebia Therapeutics

Cambridge, Massachusetts, United States

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

BiotechnologyHealth CareTherapeutics
Series CJun 4, 2013
Amount Raised: $41,000,000

Find More Investors Like Satter Investment Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Satter Investment Management | Pipeseed